Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

[Psychological care in the intensive care unit : Task areas, responsibilities, requirements, and infrastructure].

Deffner T, Michels G, Nojack A, Rößler I, Stierle D, Sydlik M, Teufert S, Ullmann U, von Bassewitz V, Wicklein K.

Med Klin Intensivmed Notfmed. 2018 Oct 26. doi: 10.1007/s00063-018-0503-1. [Epub ahead of print] Review. German.

PMID:
30367190
2.

ECEL1 gene related contractural syndrome: Long-term follow-up and update on clinical and pathological aspects.

Ullmann U, D'Argenzio L, Mathur S, Whyte T, Quinlivan R, Longman C, Farrugia ME, Manzur A, Willis T, Jungbluth H, Pitt M, Cirak S; UK10K consortium, Feng L, Stewart W, Mein R, Phadke R, Sewry C, Sarkozy A, Muntoni F.

Neuromuscul Disord. 2018 Sep;28(9):741-749. doi: 10.1016/j.nmd.2018.05.012. Epub 2018 Jun 30.

PMID:
30131190
3.

Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.

Marelli C, Lamari F, Rainteau D, Lafourcade A, Banneau G, Humbert L, Monin ML, Petit E, Debs R, Castelnovo G, Ollagnon E, Lavie J, Pilliod J, Coupry I, Babin PJ, Guissart C, Benyounes I, Ullmann U, Lesca G, Thauvin-Robinet C, Labauge P, Odent S, Ewenczyk C, Wolf C, Stevanin G, Hajage D, Durr A, Goizet C, Mochel F.

Brain. 2018 Jan 1;141(1):72-84. doi: 10.1093/brain/awx297.

PMID:
29228183
4.

A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies.

Coutelier M, Coarelli G, Monin ML, Konop J, Davoine CS, Tesson C, Valter R, Anheim M, Behin A, Castelnovo G, Charles P, David A, Ewenczyk C, Fradin M, Goizet C, Hannequin D, Labauge P, Riant F, Sarda P, Sznajer Y, Tison F, Ullmann U, Van Maldergem L, Mochel F, Brice A, Stevanin G, Durr A; SPATAX network.

Brain. 2017 Jun 1;140(6):1579-1594. doi: 10.1093/brain/awx081.

PMID:
28444220
5.

Trisomy rescue mechanism: the case of concomitant mosaic trisomy 14 and maternal uniparental disomy 14 in a 15-year-old girl.

Balbeur S, Grisart B, Parmentier B, Sartenaer D, Leonard PE, Ullmann U, Boulanger S, Leroy L, Ngendahayo P, Lungu-Silviu C, Lysy P, Maystadt I.

Clin Case Rep. 2016 Feb 2;4(3):265-71. doi: 10.1002/ccr3.501. eCollection 2016 Mar.

6.

A new double substitution mutation in the MEN1 gene: a limited penetrance and a specific phenotype.

Ullmann U, Unuane D, Velkeniers B, Lissens W, Wuyts W, Bonduelle M.

Eur J Hum Genet. 2013 Jun;21(6):695-7. doi: 10.1038/ejhg.2012.241. Epub 2012 Nov 28.

7.

Reliable and sensitive detection of fragile X (expanded) alleles in clinical prenatal DNA samples with a fast turnaround time.

Seneca S, Lissens W, Endels K, Caljon B, Bonduelle M, Keymolen K, De Rademaeker M, Ullmann U, Haentjens P, Van Berkel K, Van Dooren S.

J Mol Diagn. 2012 Nov;14(6):560-8. doi: 10.1016/j.jmoldx.2012.05.003. Epub 2012 Aug 23.

PMID:
22921311
8.

Recovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia: a randomized controlled trial.

Stuttmann R, Jakubetz J, Schultz K, Schäfer C, Langer S, Ullmann U, Hilbert P.

BMC Anesthesiol. 2010 May 7;10:5. doi: 10.1186/1471-2253-10-5.

9.

Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses.

Warnke PH, Becker ST, Springer IN, Haerle F, Ullmann U, Russo PA, Wiltfang J, Fickenscher H, Schubert S.

J Craniomaxillofac Surg. 2008 Dec;36(8):462-7. doi: 10.1016/j.jcms.2008.07.001. Epub 2008 Aug 29.

PMID:
18760616
10.

GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions.

Ullmann U, Gilles C, De Rycke M, Van de Velde H, Sermon K, Liebaers I.

Mol Hum Reprod. 2008 Mar;14(3):169-79. doi: 10.1093/molehr/gan001. Epub 2008 Feb 7.

PMID:
18263607
11.

'Grandmother penicillin'--not in vogue, but clinically still effective.

Warnke PH, Becker ST, Springer IN, Härle F, Ullmann U, Russo PA, Wiltfang J, Fickenscher H, Schubert S.

J Antimicrob Chemother. 2008 Apr;61(4):960-2. doi: 10.1093/jac/dkn030. Epub 2008 Jan 29. No abstract available.

PMID:
18230689
12.

Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions.

Ullmann U, In't Veld P, Gilles C, Sermon K, De Rycke M, Van de Velde H, Van Steirteghem A, Liebaers I.

Mol Hum Reprod. 2007 Jan;13(1):21-32. Epub 2006 Nov 7.

PMID:
17090644
13.
14.

Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations.

Schubert S, Dalhoff A, Stass H, Ullmann U.

Infection. 2005 Dec;33 Suppl 2:15-21.

PMID:
16518707
15.

Activity of human beta-defensins 2 and 3 against ESBL-producing Klebsiella strains.

Sahly H, Schubert S, Harder J, Kleine M, Sandvang D, Ullmann U, Schröder JM, Podschun R.

J Antimicrob Chemother. 2006 Mar;57(3):562-5. Epub 2006 Jan 25.

PMID:
16436542
16.

Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.

Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I, Van Steirteghem A.

Hum Reprod. 2006 Feb;21(2):503-11. Epub 2005 Nov 10.

PMID:
16284066
17.

Repeated oral once daily intake of increasing doses of the novel synthetic genistein product Bonistein in healthy volunteers.

Ullmann U, Oberwittle H, Grossmann M, Riegger C.

Planta Med. 2005 Oct;71(10):891-6.

PMID:
16254818
18.

A new Coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB.

Ullmann U, Metzner J, Schulz C, Perkins J, Leuenberger B.

J Med Food. 2005 Fall;8(3):397-9.

PMID:
16176154
19.

Epigallocatechin gallate (EGCG) (TEAVIGO) does not impair nonhaem-iron absorption in man.

Ullmann U, Haller J, Bakker GC, Brink EJ, Weber P.

Phytomedicine. 2005 Jun;12(6-7):410-5.

PMID:
16008116
20.

Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers.

Ullmann U, Metzner J, Frank T, Cohn W, Riegger C.

Adv Ther. 2005 Jan-Feb;22(1):65-78.

PMID:
15943224
21.

Bonistein (synthetic genistein), a food component in development for a bone health nutraceutical.

Ullmann U, Bendik I, Flühmann B.

J Physiol Pharmacol. 2005 Mar;56 Suppl 1:79-95. Review.

PMID:
15800387
22.

Inhibitory effects of various micro-organisms on the growth of Helicobacter pylori.

Krausse R, Piening K, Ullmann U.

Lett Appl Microbiol. 2005;40(1):81-6.

23.

Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers.

Ullmann U, Haller J, Decourt JD, Girault J, Spitzer V, Weber P.

Int J Vitam Nutr Res. 2004 Jul;74(4):269-78.

PMID:
15580809
24.

Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Sahly H, Aucken H, Benedí VJ, Forestier C, Fussing V, Hansen DS, Ofek I, Podschun R, Sirot D, Tomás JM, Sandvang D, Ullmann U.

Antimicrob Agents Chemother. 2004 Sep;48(9):3477-82.

25.

In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites.

Krausse R, Bielenberg J, Blaschek W, Ullmann U.

J Antimicrob Chemother. 2004 Jul;54(1):243-6. Epub 2004 Jun 9.

PMID:
15190039
27.

Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae.

Sahly H, Aucken H, Benedi VJ, Forestier C, Fussing V, Hansen DS, Ofek I, Podschun R, Sirot D, Sandvang D, Tomás JM, Ullmann U.

Eur J Clin Microbiol Infect Dis. 2004 Jan;23(1):20-6. Epub 2003 Dec 2.

PMID:
14652783
29.

Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease.

Krausse R, Leiendecker J, Herrmann G, Harder T, Ullmann U.

Infection. 2003 Jun;31(3):149-54.

PMID:
12789472
30.

A single ascending dose study of epigallocatechin gallate in healthy volunteers.

Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, Pineau B, Weber P.

J Int Med Res. 2003 Mar-Apr;31(2):88-101.

PMID:
12760312
31.

Burkholderia is highly resistant to human Beta-defensin 3.

Sahly H, Schubert S, Harder J, Rautenberg P, Ullmann U, Schröder J, Podschun R.

Antimicrob Agents Chemother. 2003 May;47(5):1739-41.

32.

[Serotonin syndrome].

Lheureux P, Penaloza A, De Cottenier V, Ullmann U, Gris M.

Rev Med Brux. 2002 Oct;23(5):422-8. Review. French.

PMID:
12474323
33.

Surfactant protein D binds selectively to Klebsiella pneumoniae lipopolysaccharides containing mannose-rich O-antigens.

Sahly H, Ofek I, Podschun R, Brade H, He Y, Ullmann U, Crouch E.

J Immunol. 2002 Sep 15;169(6):3267-74.

34.

[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy].

Vogel F, Scholz H, al-Nawas B, Elies W, Kresken M, Lode H, Müller O, Naber KG, Petersen E, Shah P, Sörgel F, Stille W, Tauchnitz C, Trautmann M, Ullmann U, Wacha H, Wiedemann B; Paul Ehrlich Society for Chemotherapy.

Med Monatsschr Pharm. 2002 Jun;25(6):193-204. German. No abstract available.

PMID:
12109028
35.

New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections.

Harder TC, Hufnagel M, Zahn K, Beutel K, Schmitt HJ, Ullmann U, Rautenberg P.

J Clin Microbiol. 2001 Dec;39(12):4413-9.

36.

Clinical relevance of CagA-specific antibodies related to CagA status of Helicobacter pylori isolates using immunofluorescence test and PCR.

Krausse R, Garten L, Harder T, Ullmann U, Birkner T, Doniec M, Grimm H.

Infection. 2001 May-Jun;29(3):154-8.

PMID:
11440386
37.

Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.

Ullmann U, Lehnfeld R, Bliesath H, Birkel M, Gebbing H, Gräve M, Wolf H.

Int J Clin Pharmacol Ther. 2001 Jun;39(6):271-6.

PMID:
11430636
38.

Incidence of Klebsiella species in surface waters and their expression of virulence factors.

Podschun R, Pietsch S, Höller C, Ullmann U.

Appl Environ Microbiol. 2001 Jul;67(7):3325-7.

39.
40.

Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae.

Sahly H, Podschun R, Oelschlaeger TA, Greiwe M, Parolis H, Hasty D, Kekow J, Ullmann U, Ofek I, Sela S.

Infect Immun. 2000 Dec;68(12):6744-9.

41.
42.

[Results of an evaluation of psychotherapeutic care from the viewpoints of patients and therapists in Saxony-Anhalt].

Kühn A, Liedtke A, Wunschel I, Schulze H, Ullmann U, Kleinschmidt U, Hennig H.

Psychother Psychosom Med Psychol. 2000 Aug;50(8):322-7. German.

PMID:
11004887
43.

Klebsiella infections in the immunocompromised host.

Sahly H, Podschun R, Ullmann U.

Adv Exp Med Biol. 2000;479:237-49. Review. No abstract available.

PMID:
10897425
44.

Infection and chronic colonization of an intensive care unit patient's respiratory tract by a Klebsiella pneumoniae strain producing a novel AmpC beta-lactamase different from that known.

Sahly H, Boehme V, Podschun R, Bauernfeind A, Fölsch UR, Ullmann U.

Clin Infect Dis. 1999 Jun;28(6):1338-9. No abstract available.

PMID:
10451189
45.

A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.

Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U.

Antimicrob Agents Chemother. 1999 Aug;43(8):1924-31.

46.
47.
48.

Increased antibody responses to Klebsiella serotypes K26, K36, and K50 in patients with ankylosing spondylitis.

Sahly H, Podschun R, Ullmann U.

Rheumatology (Oxford). 1999 May;38(5):481-2. No abstract available.

PMID:
10371297
49.
50.

Supplemental Content

Loading ...
Support Center